ARTICLE
13 January 2016

Hazy Outlook

E-Cigarettes have become increasingly popular since they entered the marker almost 10 years ago. Product innovation is the norm.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

E-Cigarettes have become increasingly popular since they entered the marker almost 10 years ago. Product innovation is the norm. Most importantly, there's growing discussion about the role e-cigarettes may play in a tobacco harm reduction strategy. An uncertain regulatory future, however, could limit consumer choice, stifle product innovation and end a promising discussion on a means of protecting the public health – one of the primary pillars of the U.S. Food and Drug Administration's (FDA) mandate in regulating tobacco.

Click here to view full article

Originally published by Vapor Voice.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More